Lifeward regains NASDAQ minimum bid price compliance

Lifeward Ltd. (NASDAQ: LFWD) announced it has regained compliance with NASDAQ's minimum bid price requirement after receiving confirmation from The NASDAQ Stock Market LLC on March 11, 2026.

The medical technology company's common stock maintained a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, satisfying the requirement on March 9, 2026. NASDAQ Listing Rule 5550(a)(2) sets the minimum bid price standard for listed companies.

The NASDAQ Listing Qualifications Staff has closed the prior bid price deficiency matter, and Lifeward's ordinary shares will continue trading on The NASDAQ Capital Market.

Lifeward develops medical technology solutions for physical rehabilitation and recovery. The company's product portfolio includes the ReWalk Exoskeleton, AlterG Anti-Gravity System, MyoCycle FES System, and ReStore Exo-Suit.

Founded in 2001, the company operates in the United States, Israel, and Germany. The announcement was made in a company press release.

You May Also Be Interested In

• Helus Pharma shareholders approve name change from Cybin Inc.
• Solaris Energy prices upsized $1.25B senior notes offering
• Angi names Michael Steib as CEO, replacing Jeff Kip